Research output per year
Research output per year
Personal profile
Research interests
My research focuses on studying the inherited basis of cardiovascular disease at the intersection of computational biology and human genetics. Using a variety of techniques in genomics and bioinformatics, my laboratory is interested in: 1) Identifying novel genes and pathways underlying both Mendelian and complex forms of disease; 2) Developing innovative computational methods for the analysis of complex genetic data; and 3) Applying insights gained from human genetics to improve patient care.
Clinical interests
Cardiovascular genetics; inherited cardiovascular disease; genetic syndromes; cardiomyopathy, arrhythmia genetics
Available to Mentor:
- PhD/MSTP Students
Fingerprint
Dive into the research topics where Nathan Stitziel is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Clinical Insights from Proteomics in Heart Failure
Lotfinaghsh, A., Imam, A., Pompian, A., Stitziel, N. O. & Javaheri, A., Dec 2025, In: Current Heart Failure Reports. 22, 1, 12.Research output: Contribution to journal › Review article › peer-review
-
Decoding the Therapeutic Target SVEP1: Harnessing Molecular Trait GWASs to Unravel Mechanisms of Human Disease
Elenbaas, J. S., Lee, P. C., Patel, V. & Stitziel, N. O., Jan 23 2025, In: Annual Review of Pharmacology and Toxicology. 65, 1, p. 131-148 18 p.Research output: Contribution to journal › Review article › peer-review
Open Access1 Scopus citations -
Molecular Regulation and Therapeutic Targeting of VLDL Production in Cardiometabolic Disease
Burks, K. H., Stitziel, N. O. & Davidson, N. O., Jan 2025, In: CMGH. 19, 1, 101409.Research output: Contribution to journal › Review article › peer-review
Open Access -
Plasma SVEP1 Levels Predict Cardiovascular Events in Hypertrophic Cardiomyopathy Beyond Conventional Clinical Risk Models Including NT-proBNP
Osawa, I., Akita, K., Hasegawa, K., Fifer, M. A., Tower-Rader, A., Reilly, M. P., Maurer, M. S., Stitziel, N. O., Javaheri, A. & Shimada, Y. J., Feb 1 2025, In: Circulation: Heart Failure. 18, 2, p. e012343Research output: Contribution to journal › Article › peer-review
-
Reducing the Risk of Pancreatitis by Inhibiting APOC3
Stitziel, N. O., Jan 9 2025, In: New England Journal of Medicine. 392, 2, p. 197-199 3 p.Research output: Contribution to journal › Editorial